Logo image of ZK

ZEEKR INTELLIGENT TECHNO-ADR (ZK) Stock Fundamental Analysis

USA - NYSE:ZK - US98923K1034 - ADR

29.48 USD
+0.3 (+1.03%)
Last: 10/16/2025, 8:22:12 PM
29.48 USD
0 (0%)
After Hours: 10/16/2025, 8:22:12 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZK. ZK was compared to 37 industry peers in the Automobiles industry. ZK has a bad profitability rating. Also its financial health evaluation is rather negative. ZK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZK has reported negative net income.
ZK Yearly Net Income VS EBIT VS OCF VS FCFZK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2B -2B -4B -6B -8B

1.2 Ratios

ZK has a Return On Assets of -5.39%. This is in the better half of the industry: ZK outperforms 64.86% of its industry peers.
Industry RankSector Rank
ROA -5.39%
ROE N/A
ROIC N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZK Yearly ROA, ROE, ROICZK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

ZK has a Gross Margin of 18.91%. This is in the better half of the industry: ZK outperforms 75.68% of its industry peers.
ZK's Gross Margin has been stable in the last couple of years.
ZK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
ZK Yearly Profit, Operating, Gross MarginsZK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

ZK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZK has been increased compared to 1 year ago.
ZK has a worse debt/assets ratio than last year.
ZK Yearly Shares OutstandingZK Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M 200M 250M
ZK Yearly Total Debt VS Total AssetsZK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.27, we must say that ZK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.27, ZK perfoms like the industry average, outperforming 54.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.27
ROIC/WACCN/A
WACC5.73%
ZK Yearly LT Debt VS Equity VS FCFZK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5B -5B -10B

2.3 Liquidity

A Current Ratio of 0.59 indicates that ZK may have some problems paying its short term obligations.
ZK's Current ratio of 0.59 is on the low side compared to the rest of the industry. ZK is outperformed by 70.27% of its industry peers.
ZK has a Quick Ratio of 0.59. This is a bad value and indicates that ZK is not financially healthy enough and could expect problems in meeting its short term obligations.
ZK's Quick ratio of 0.49 is on the low side compared to the rest of the industry. ZK is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.49
ZK Yearly Current Assets VS Current LiabilitesZK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.83% over the past year.
ZK shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.98%.
The Revenue has been growing by 126.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)60.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.33%
Revenue 1Y (TTM)38.98%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%

3.2 Future

The Earnings Per Share is expected to grow by 40.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 38.00% on average over the next years. This is a very strong growth
EPS Next Y50.48%
EPS Next 2Y46.33%
EPS Next 3Y40.84%
EPS Next 5YN/A
Revenue Next Year56.8%
Revenue Next 2Y42.91%
Revenue Next 3Y38%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZK Yearly Revenue VS EstimatesZK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
ZK Yearly EPS VS EstimatesZK Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ZK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 450.33 indicates a quite expensive valuation of ZK.
ZK's Price/Forward Earnings ratio is in line with the industry average.
ZK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.85.
Industry RankSector Rank
PE N/A
Fwd PE 450.33
ZK Price Earnings VS Forward Price EarningsZK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZK Per share dataZK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZK does not grow enough to justify the current Price/Earnings ratio.
ZK's earnings are expected to grow with 40.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.33%
EPS Next 3Y40.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEEKR INTELLIGENT TECHNO-ADR

NYSE:ZK (10/16/2025, 8:22:12 PM)

After market: 29.48 0 (0%)

29.48

+0.3 (+1.03%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-14 2025-11-14
Inst Owners3.4%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.55B
Analysts85
Price Target36.76 (24.69%)
Short Float %0.2%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-52.16%
Min EPS beat(2)-161.65%
Max EPS beat(2)57.34%
EPS beat(4)2
Avg EPS beat(4)-311.1%
Min EPS beat(4)-1188.89%
Max EPS beat(4)57.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.63%
Min Revenue beat(2)-3.75%
Max Revenue beat(2)15.01%
Revenue beat(4)2
Avg Revenue beat(4)3.68%
Min Revenue beat(4)-4.51%
Max Revenue beat(4)15.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)65.29%
EPS NY rev (1m)0%
EPS NY rev (3m)14.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)2.77%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 450.33
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)0.07
Fwd EY0.22%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS49.62
BVpS-13.18
TBVpS-14.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.91%
FCFM N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.49
Altman-Z 0.27
F-ScoreN/A
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)291.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.33%
EPS Next Y50.48%
EPS Next 2Y46.33%
EPS Next 3Y40.84%
EPS Next 5YN/A
Revenue 1Y (TTM)38.98%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%
Revenue Next Year56.8%
Revenue Next 2Y42.91%
Revenue Next 3Y38%
Revenue Next 5YN/A
EBIT growth 1Y53.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.21%
EBIT Next 3Y59.62%
EBIT Next 5YN/A
FCF growth 1Y312.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.62%
OCF growth 3Y71.86%
OCF growth 5YN/A